We found that both MV4‐11 and MOLM13 cells (carrying FLT3‐ITD) were both of the most sensitive to ACC010 and HHT, whereas U937 was relatively resistant to both drugs in AML cell lines (Fig. 1A). The gene discussed is FLT3; the disease is acute myeloid leukemia.